Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Merck (MRK) shares in India

Learn how to easily invest in Merck shares.

Merck
NYSE: MRK - USD
$93.55
+ $1.46 ( + 1.59%)
DRUG MANUFACTURERS-GENERAL

Merck & Co. Inc (MRK) is a leading drug manufacturers-general business based in the US. It opened the day at USD$81.6 after a previous close of USD$81.32. During the day the price has varied from a low of USD$80.765 to a high of USD$81.8521. The latest price was USD$81.38 (25 minute delay). Merck is listed on the NYSE and employs 67,000 staff. All prices are listed in US Dollars.

Compare online trading platforms

Name Product Number of stocks CFDs Shares Available Markets Link
Saxo Bank
19,000+
Yes
Yes
US, CA, ES, NL, IE, UK, IT, DK, FI, SE, BG, PT, FR, CZ, CH, AT, PL, ZA, AU, HK, MY, HK-CH, SG, JP, MX, DE, NO, RU
Go to site
CFD service. Your capital is at risk.
More info
CFD Service. Your capital is at risk.
Trade 40,000+ financial instruments at market-leading prices with this powerful yet intuitive trading platform.
Zacks Trade
Access to global markets
No
Yes
US, CA, ES, NL, UK, IT, SE, BG, FR, CH, AT, AU, HK, SG, JP
Go to site
More info
CFD Service. Your capital is at risk.
Trade stocks, bonds, ETFs, options, and more on 90+ international exchanges. Offers customisable trading platforms with over 120 technical indicators for your charting needs.
Axis Direct
All NSE/BSE listed stocks
No
Yes
US, IN
More info
Get brokerage cashback of up to Rs 500 on trades done online through Axis Direct website, Swift Trade, or Mobile app. Grow your investment portfolio and maximise your gains with AxisDirect’s 3-in-1 demat, trading and savings account.
TradeSmart
All NSE/BSE listed stocks
No
Yes
IN
More info
CFD Service. Your capital is at risk.
Achieve your financial objectives and trade various financial instruments with India’s leading discount broker.
Exness
N/A
Yes
No
IN, SA, SG, VN, TH, PH, ID, UAE, ZA, EG, BR, CR, MX
CFD service. Your capital is at risk.
More info
CFD Service. Your capital is at risk.
Enjoy fast trade executions at competitive fees with this award-winning retail forex broker.
loading

Compare up to 4 providers

How has Coronavirus impacted Merck's stock price?

Since the stock market crash in March caused by coronavirus, Merck's stock price has had significant positive movement.

Its last market close was $93.55, which is 11.98% up on its pre-crash value of $82.34 and 43.37% up on the lowest point reached during the March crash when the stocks fell as low as $65.25.

If you had bought $1,000 worth of Merck stocks at the start of February 2020, those stocks would have been worth $760.28 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,071.15.

Is it a good time to buy Merck stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Merck shares at a glance

Information last updated 2022-01-14.
Open$81.60
High$81.85
Low$80.77
Close$81.38
Previous close$81.32
Change $0.06
Change % 0.0738%
Volume 9,478,020
Information last updated 2022-05-16.
52-week range$69.02 - $92.87
50-day moving average $83.76
200-day moving average $79.51
Wall St. target price$95.73
PE ratio 16.1822
Dividend yield $2.64 (3.05%)
Earnings per share (TTM) $5.59

Merck stock price (NYSE:MRK)

Use our graph to track the performance of MRK stocks over time.

Merck price performance over time

Historical closes compared with the close of $81.38 from 2022-05-20

1 week (2022-05-16) -11.85%
1 month (2022-04-22) -3.79%
3 months (2022-02-19) N/A
6 months (2021-11-23) -1.71%
1 year (2021-05-21) 2.78%
2 years (2020-05-22) 6.64%
3 years (2019-05-22) 0.57%
5 years (2017-05-22) 27.17%

Is Merck under- or over-valued?

Valuing Merck stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merck's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Merck's P/E ratio

Merck's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Merck shares trade at around 16x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Merck's PEG ratio

Merck's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1542. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merck's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Merck's EBITDA

Merck's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $21.6 billion.

The EBITDA is a measure of a Merck's overall financial performance and is widely used to measure a its profitability.

Merck financials

Revenue TTM $54 billion
Operating margin TTM 34.41%
Gross profit TTM $35.5 billion
Return on assets TTM 10.05%
Return on equity TTM 38.82%
Profit margin 26.27%
Book value $15.11
Market capitalisation $228.6 billion

TTM: trailing 12 months

Merck's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Merck.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Merck's total ESG risk score

Total ESG risk: 28.35

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Merck's overall score of 28.35 (as at 12/31/2018) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Merck is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Merck's environmental score

Environmental score: 3.15/100

Merck's environmental score of 3.15 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Merck is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Merck's social score

Social score: 15.55/100

Merck's social score of 15.55 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Merck is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Merck's governance score

Governance score: 12.65/100

Merck's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Merck is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Merck's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Merck scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Merck hasn't always managed to keep its nose clean.

Merck share dividends

38%

Dividend payout ratio: 38.29% of net profits

Recently Merck has paid out, on average, around 38.29% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.05% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Merck shareholders could enjoy a 3.05% return on their shares, in the form of dividend payments. In Merck's case, that would currently equate to about $2.64 per share.

While Merck's payout ratio might seem fairly standard, it's worth remembering that Merck may be investing much of the rest of its net profits in future growth.

Merck's most recent dividend payout was on 6 April 2022. The latest dividend was paid out to all shareholders who bought their shares by 13 March 2022 (the "ex-dividend date").

Have Merck's shares ever split?

Merck's shares were split on a 1048:1000 basis on 2 June 2021. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1048 shares. This wouldn't directly have changed the overall worth of your Merck shares – just the quantity. However, indirectly, the new 4.6% lower share price could have impacted the market appetite for Merck shares which in turn could have impacted Merck's share price.

Merck share price volatility

Over the last 12 months, Merck's shares have ranged in value from as little as $69.0248 up to $92.87. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Merck's is 0.4608. This would suggest that Merck's shares are less volatile than average (for this exchange).

Merck overview

Merck & Co. , Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy Policy and Terms.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site